Global Peptide Therapeutics Market to be Worth US$25.4

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research

Albany, NY, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Transparency Market Research, in its report titled 'Peptide Therapeutics Market (by Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, Metabolic, CVS, CNS & others, by Types - Innovative & Generic and by Delivery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018', states that the global peptide therapeutics market was worth US$14.1 billion in 2011 and is expected to reach US$25.4 billion by 2018 at an 8.7% CAGR.

The two main types of peptide therapeutics are innovative and generic. Peptide therapeutics finds applications in disciplines such as cardiovascular, dermatology, metabolic, cancer, neurology, gastro intestinal, pain, renal, anti-infection, and respiratory. On the basis of route of administration, peptide therapeutics can be segmented into oral, parenteral, mucosal, and pulmonary. On the basis of technology, peptide therapeutics is divided into solid phase peptide synthesis, liquid phase peptide synthesis, and hybrid. On the basis of API peptide, the market for peptide therapeutics is categorized into in-house and contract manufacturing organization.

Browse Full Report : http://www.transparencymarketresearch.com/pep...arket.html

Among the major applications, cancer peptide was the largest segment, accounting for 21% of the peptide therapeutics market. With rising incidences of Parkinson's and Alzheimer's disease, the neuropeptides segment will grow at 9.4% CAGR in the forecast period. Among the main routes of peptide therapeutics administration, the parenteral segment accounted for 86% of the market share in 2011. Combing the best of both solid and liquid phase peptide synthesis, the hybrid technology segment of the peptide therapeutics market is expected to register the highest CAGR of 12.1% during the forecast period. North America dominated the global peptide therapeutics market, accounting for 40% of the overall industry.

Some of the major factors that fuel the peptide therapeutics market are increasing number of cancer patients, rising cases of metabolic disorders, technological advancement, and mounting R&D activities as well as pipeline drugs in the field of peptide therapeutics. With the possibility of patent cliff in the near future, the generic peptide segment is expected to grow significantly, thereby leading to the overall propulsion of the peptide therapeutics market. In addition, industry analysts foresee great potential in the collaboration of small peptide therapeutics firms with major pharmaceutical companies. Rising cancer vaccines are also expected to stimulate the peptide therapeutics market.

Get The Sample Report PDF : http://www.transparencymarketresearch.com/sam...rep_id=418

However, absence of effective regularity standards for peptide therapeutics, attempting to match customer requirements with the equipment, and rising complexities of peptides are expected to inhibit the global peptide therapeutics market.

Related Published Report By Transparency Market Research :

As the global peptide therapeutics market gains significance, there has been a surge of new entrants in the industry. Some of the major peptide therapeutics companies include Roche, Ipsen, Novo-Nordisk, Eli LillyAmylin. The CMOs in the peptide therapeutics market include Peptisyntha, Bachem, Lonza, and Polypeptide Group.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

CONTACT: Sheela AK 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA/Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Web: http://www.transparencymarketresearch.com/ Blog: http://www.tmrblog.com/ Blog: http://transparencymarketresearch.areavoices.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 0

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Zunyi’s History Tour Carries China’s Story Overseas

Updated Category News Views 46

China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 49

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 118

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 25

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 171

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 65

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
CATL Makes Its APEC Case Beyond the Electric Car Market

Updated Category News Views 10

A 99-Second Pitch With Bigger Ambitions Battery swapping got a rare moment in the geopolitical sunlight at Shenzhen's APEC CEO Summit, and CATL was plainly trying to make that moment count. Dr. Robin Zeng, the company's founder, chairman and chief executive, used the opening business dialogue to argue that the Asia-Pacific region holds more opportunity than trouble. Fair...

Continue Reading
Diwali at Heritage Shows the Real Estate Community Test

Updated Category News Views 89

Fireworks do not sell a townhome by themselves, but belonging can sure help close the distance between a brochure and a serious purchase. Heritage at South Brunswick recently held a Diwali celebration sponsored by American Properties at South Brunswick LLC, bringing homeowners, families, and the builder's team into the same room for an evening of food, music, dancing,...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 321

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

GRAX Honored as Cybersecurity Innovator by BostInno Awards

Updated Category News Views 66

GRAX Recognized as a Leader in Cybersecurity GRAX, Inc., well-known for its innovation in Salesforce data management and protection, has recently earned an esteemed recognition as a 2024 Fire honoree in cybersecurity from BostInno. This award celebrates companies that are driving innovation in the Boston area, emphasizing GRAX's role as a pioneer in data security....

Continue Reading
i2Cool and Marubeni Join Forces for Revolutionary Cooling Tech

Updated Category News Views 286

i2Cool and Marubeni Forge Strategic Partnership i2Cool, a pioneering company in the realm of electricity-free cooling technology, has established a significant global partnership with Marubeni, a prominent trading company from Japan. This collaboration is designed to facilitate the widespread adoption of electricity-free cooling technologies, concentrating particularly on...

Continue Reading
Jasper Therapeutics Upcoming Investor Conferencs - September 2024

Updated Category News Views 82

Jasper Therapeutics to Showcase Innovations at September Events Jasper Therapeutics, Inc. (NASDAQ: JSPR), a leader in biotechnology, is preparing for a series of investor conferences this September. The company is particularly excited to discuss briquilimab, an innovative antibody therapy designed to treat c-Kit (CD117) driven mast cell diseases, including chronic...

Continue Reading
Tech Sector Thrives as Meta Drives Nasdaq-100 to New Heights

Updated Category News Views 303

Tech Sector Soars with New Nasdaq-100 Records The Nasdaq-100 has reached an unprecedented high of 22,191.37, highlighting the unyielding strength of tech stocks. The renowned Invesco QQQ Trust (NASDAQ: QQQ) has also achieved a 52-week peak, reaching $540, demonstrating the energetic rally across the technology market. Meta Platforms Inc's Remarkable Performance Meta...

Continue Reading
Millicom Advances Infrastructure Sale and Special Dividend Plans

Updated Category News Views 207

Millicom Announces Infrastructure Deal Progress Millicom International Cellular S.A. (NASDAQ: TIGO) has made significant strides in its transaction with SBA Communications. The company recently revealed the partial closing of its sale involving LATI International S.A., the holding company for its mobile passive infrastructure assets in Central America. This deal has...

Continue Reading